MissionIR Articles

BioLife Solutions, Inc. (NASDAQ: BLFS) is located in Bothell, Washington, on a high-tech campus that has roots as a dairy farm. The company manufactures and markets proprietary protein-free, serum-free cGMP biopreservation media for cells, tissues…

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is on a quest to expand immune system stimulation to revolutionize the fight against cancers and infectious diseases. Stimulating the body’s immune system remains one of the most promising approaches…

Chembio Diagnostics, Inc. (NASDAQ: CEMI) is committed to delivering exceptional products that provide ease of use, and rapid and accurate results at the point-of-care (POC). At the core of its commitment is its patented Next…

Bionik Laboratories Corp. (OTC: BNKL), a medical device and robotics company, focuses on robotic exoskeleton technology for those with mobility impairments. The technology gives users a chance to rehabilitate effectively by being able to walk.…

Asterias Biotherapeutics, Inc. (NYSE: AST) is engaged in the emerging field of regenerative medicine. The company’s proprietary platforms are based on its pluripotent stem cell and dendritic cell immunotherapy technologies. Asterias’ portfolio includes: AST-OPC1, currently…

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is a clinical-stage drug development company targeting rare, chronic and serious inflammatory and fibrotic diseases with clear unmet needs. The company’s lead product candidate, Resunab, is a first-in-class, synthetic…

Arch Therapeutics (NASDAQ: ARTH), a medical device company, offers an innovative approach to rapid cessation of bleeding and control of fluid during surgery and trauma care. The underlying technology, exclusively licensed from a leading university,…

Galmed Pharmaceuticals (NASDAQ: GLMD) is a clinical-stage biopharmaceutical focused on the development and commercialization of therapeutics for the treatment of liver diseases. The company is developing Aramchol, which is in phase 2b clinical trial for…

ContraFect Corp. (NASDAQ: CFRX) is a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. The company is finding answers to drug-resistant and newly-emerging pathogens…

Cellular Biomedicine Group (NASDAQ: CBMG) is a biomedicine company principally engaged in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. The company is focused on developing and marketing safe…

Sevion Therapeutics, Inc. (OTC: SVON) discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The company is advancing a pipeline of proprietary and partnered product candidates that leverages its…

Biotron Ltd. (OTC: BITRF) is an Australian biotechnology company based in Sydney. The company develops and commercializes novel small molecule antiviral therapeutics targeting Hepatitis C virus (HCV) and HIV-1. Biotron’s lead drug, BIT225 is in…

Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV) is a biopharmaceutical company focused on the development of therapeutic candidates for the simultaneous treatment of various clinical conditions. Kitov focuses on developing combinations of existing drugs in advanced…

Rexahn Pharmaceuticals, Inc. (NYSE: RNN) is a clinical-stage biopharmaceutical company dedicated to the development of novel, best-in-class therapeutics for the treatment of cancer. The company’s product candidates work by targeting and neutralizing specific proteins believed…

BIND Therapeutics, Inc. (NASDAQ: BIND) is a clinical-stage nanomedicine company developing a pipeline of ACCURINS®, its novel targeted therapeutics designed to increase the concentration and duration of therapeutic payloads at disease sites while reducing exposure…

Capricor Therapeutics, Inc. (NASDAQ: CAPR) is focused on discovering, developing and marketing first-in-class therapeutics for the treatment of diseases. Presently, the company is positioned at the forefront of one of the largest segments of the…

Neurometrix (NASDAQ: NURO) is an innovative health-care company that develops wearable medical technology and point-of-care test that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company’s expertise in biomedical…

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is on a quest to redefine the life of the spinal cord injury patient. Armed with cutting-edge technology and MIT science, experienced business and medical professionals at InVivo Therapeutics…

Fate Therapeutics, Inc. (NASDAQ: FATE) is a clinical‑stage biopharmaceutical company engaged in the development of programmed cellular therapeutics for the treatment of severe, life‑threatening diseases. The company is primarily focused on developing programmed hematopoietic cellular…

CymBay Therapeutics, Inc. (NASDAQ: CBAY) is a clinical-stage biopharmaceutical company developing therapies to treat metabolic diseases with high unmet medical need, including serious rare and orphan disorders. The company’s portfolio includes arhalofenate, which has shown…